ATE135006T1 - Chinuclidinderivate - Google Patents

Chinuclidinderivate

Info

Publication number: ATE135006T1
Authority: AT; Austria
Prior art keywords: quinuclidine derivatives; quinuclidine; derivatives
Prior art date: 1991-05-31

Application number

AT92912601T

Other languages

English (en)

Inventor

Fumitaka Ito

Hiroshi Kondo

Kaoru Shimada

Masami Nakane

John Adams Lowe Iii

Terry Jay Rosen

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-31

Filing date

1992-04-28

Publication date

1996-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24845673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE135006(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-04-28 Application filed by Pfizer filed Critical Pfizer

1996-03-15 Application granted granted Critical

1996-03-15 Publication of ATE135006T1 publication Critical patent/ATE135006T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Psychiatry (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT92912601T 1991-05-31 1992-04-28 Chinuclidinderivate ATE135006T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US70840491A	1991-05-31	1991-05-31

Publications (1)

Publication Number	Publication Date
ATE135006T1 true ATE135006T1 (de)	1996-03-15

Family

ID=24845673

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92912601T ATE135006T1 (de)	1991-05-31	1992-04-28	Chinuclidinderivate

Country Status (41)

Country	Link
US (3)	US5807867A (de)
EP (1)	EP0587723B1 (de)
JP (2)	JPH0733386B2 (de)
KR (1)	KR100214905B1 (de)
CN (1)	CN1048492C (de)
AP (1)	AP299A (de)
AT (1)	ATE135006T1 (de)
AU (1)	AU657552B2 (de)
BG (1)	BG61694B1 (de)
BR (1)	BR9206073A (de)
CA (1)	CA2102179C (de)
CZ (1)	CZ281403B6 (de)
DE (4)	DE122006000066I2 (de)
DK (1)	DK0587723T3 (de)
EG (1)	EG19944A (de)
ES (1)	ES2084361T3 (de)
FI (1)	FI114475B (de)
GR (1)	GR3019687T3 (de)
GT (1)	GT199200028A (de)
HU (1)	HU217548B (de)
IE (1)	IE72473B1 (de)
IL (1)	IL102008A (de)
IS (1)	IS1611B (de)
LU (1)	LU91293I2 (de)
MA (1)	MA22539A1 (de)
MX (1)	MX9202554A (de)
NL (1)	NL300250I2 (de)
NO (2)	NO302701B1 (de)
NZ (2)	NZ270673A (de)
OA (1)	OA09867A (de)
PL (1)	PL171379B1 (de)
PT (1)	PT100546B (de)
RO (1)	RO110499B1 (de)
RU (1)	RU2103269C1 (de)
SK (1)	SK278788B6 (de)
TW (1)	TW204349B (de)
UA (1)	UA27776C2 (de)
UY (1)	UY23422A1 (de)
WO (1)	WO1992021677A1 (de)
YU (1)	YU48995B (de)
ZA (1)	ZA923942B (de)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE122006000066I2 (de) *	1991-05-31	2007-12-06	Pfizer	Chinuclidinderivate
HU221634B1 (hu) *	1991-06-20	2002-12-28	Pfizer Inc.	Nitrogéntartalmú heterociklusos vegyületek fluor-alkoxi-benzilamino-származékai, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
ATE208376T1 (de) *	1992-08-19	2001-11-15	Pfizer	Substituierte benzylamin-stickstoff enthaltende nichtaromatische heterocyclen
ES2096312T3 (es) *	1992-11-12	1997-03-01	Pfizer	Derivado de quinuclidina como antagonista de la sustancia p.
US5344830A (en) *	1992-12-10	1994-09-06	Merck & Co., Inc.	N,N-diacylpiperazine tachykinin antagonists
IL109646A0 (en) *	1993-05-19	1994-08-26	Pfizer	Heteroatom substituted alkyl benzylamino-quinuclidines
JP2822274B2 (ja) *	1993-05-19	1998-11-11	ファイザー製薬株式会社	Ｐ物質拮抗剤としてのヘテロ原子置換アルキルベンジルアミノキヌクリジン類
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
EP0653208A3 (de) *	1993-11-17	1995-10-11	Pfizer	Substanz P Antagonisten zur Behandlung oder Verhütung des sonnenbrandes.
EP0659409A3 (de) *	1993-11-23	1995-08-09	Pfizer	Substanz P Antagonisten zur Hemmung der Angiogenese.
EP0655246A1 (de) *	1993-11-30	1995-05-31	Pfizer Inc.	Substanz P Antagonisten zur Behandlung von durch Helicobacter Pylori oder andere spirale Urease-positive Gram-negative Bakterien verursachten Krankheiten
IL116249A (en) *	1994-12-12	2003-07-06	Pfizer	Nk-1 receptor antagonists for the treatment of neuronal damage and stroke
PE8798A1 (es) *	1995-07-17	1998-03-02	Pfizer	Procedimiento de separacion de los enantiomeros del 1-azabiciclo[2.2.2] octan-3-amina, 2-(difenilmetil) -n- [[2-metoxi-5-(1-metiletil) fenil] metil]
TW458774B (en)	1995-10-20	2001-10-11	Pfizer	Antiemetic pharmaceutical compositions
IL123740A0 (en) *	1997-03-28	1998-10-30	Pfizer	NK-1 receptor antagonists for the treatment of delayed emesis
NZ329807A (en) *	1997-04-23	2000-07-28	Pfizer	NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
AR018772A1 (es) *	1998-03-19	2001-12-12	Takeda Chemical Industries Ltd	Composicion farmaceutica para prevenir o tratar depresion, inquietud, enfermedad maniaca depresiva o psicopatia, compuesto heterociclico comprendido en lamisma, prodroga obtenida a partir del anterior, metodo para producir dicho compuesto y su uso
US6255320B1 (en) *	1999-06-01	2001-07-03	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
US6387925B1 (en) *	1999-06-01	2002-05-14	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions
US6262067B1 (en) *	1999-06-22	2001-07-17	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions
CA2324116A1 (en) *	1999-10-25	2001-04-25	Susan Beth Sobolov-Jaynes	Nk-1 receptor antagonists and eletriptan for the treatment of migraine
US7163949B1 (en)	1999-11-03	2007-01-16	Amr Technology, Inc.	4-phenyl substituted tetrahydroisoquinolines and use thereof
CA2389306C (en)	1999-11-03	2010-03-30	Albany Molecular Research, Inc.	Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
IL142810A0 (en) *	2000-05-03	2002-03-10	Pfizer Prod Inc	Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
BR0112350A (pt)	2000-07-11	2003-06-24	Albany Molecular Res Inc	Composto, composição farmacêutica, e, método de tratar um animal afligido por um distúrbio neurológico ou psicológico
US20020049211A1 (en) *	2000-09-06	2002-04-25	Sobolov-Jaynes Susan Beth	Combination treatment for depression and anxiety
EP1192952A3 (de) *	2000-09-28	2003-03-26	Pfizer Products Inc.	Ein NK-3 rezeptorantagonisten und ein ZNS-penetrierende NK-1 rezeptorantagonisten enthaltende Zusammensetzung zur Behandlung von Depression und Angst
JP2005504029A (ja) *	2001-07-20	2005-02-10	ファイザー・プロダクツ・インク	犬の好ましくない行動を改善するためのｎｋ−１受容体アンタゴニストの使用
US6686507B2 (en)	2002-03-06	2004-02-03	Pfizer Inc	Purification of 2-methoxy-5-trifluoromethoxybenzaldehyde
GB0220581D0 (en) *	2002-09-04	2002-10-09	Novartis Ag	Organic Compound
US6861526B2 (en)	2002-10-16	2005-03-01	Pfizer Inc.	Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
NZ569331A (en) *	2003-01-21	2010-08-27	Yeda Res & Dev	COP 1 for treatment of inflammatory bowel diseases
US20050112695A1 (en) *	2003-10-27	2005-05-26	Meyer Donald W.	Method of detecting bovine spongiform encephalopathy
WO2005051919A1 (en) *	2003-11-26	2005-06-09	Pfizer Products Inc.	Aminopyrazole derivatives as gsk-3 inhibitors
AU2005216706B2 (en) *	2004-01-30	2007-11-29	Pfizer Products Inc.	NK-1 receptor antagonists anesthesia recovery
JP5021318B2 (ja) *	2004-01-30	2012-09-05	ファイザー・プロダクツ・インク	β−シクロデキストリンを液体投薬形態に用いて多用量製剤を達成するための抗菌性防腐剤
RU2320659C9 (ru) *	2004-02-02	2008-07-20	Пфайзер Продактс Инк.	Способы получения 1-(2s, 3s)-2-бензгидрил-n-(5-трет-бутил-2-метоксибензил)хинуклидин-3-амина в виде камфорсульфатной соли, цитратной соли и свободного основания и промежуточное соединение
AU2005274927B2 (en)	2004-07-15	2011-11-03	Albany Molecular Research, Inc.	Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ATE550019T1 (de)	2005-05-17	2012-04-15	Merck Sharp & Dohme	Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs
JP5258561B2 (ja)	2005-07-15	2013-08-07	アルバニーモレキュラーリサーチ，インコーポレイテッド	アリール置換およびヘテロアリール置換テトラヒドロベンズアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用
AU2006297443B2 (en)	2005-09-29	2010-08-12	Merck Sharp & Dohme Corp.	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
GB0603041D0 (en)	2006-02-15	2006-03-29	Angeletti P Ist Richerche Bio	Therapeutic compounds
JP5489333B2 (ja)	2006-09-22	2014-05-14	メルク・シャープ・アンド・ドーム・コーポレーション	脂肪酸合成阻害剤を用いた治療の方法
US20110218176A1 (en)	2006-11-01	2011-09-08	Barbara Brooke Jennings-Spring	Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
CN101190330A (zh)	2006-11-30	2008-06-04	深圳市鼎兴生物医药技术开发有限公司	胆碱酯酶在拮抗速激肽药物中的应用
PL2805945T3 (pl)	2007-01-10	2019-09-30	Msd Italia S.R.L.	Indazole podstawione grupą amidową jako inhibitory polimerazy poli(adp-rybozy) - (parp)
CN101641099A (zh)	2007-01-24	2010-02-03	葛兰素集团有限公司	包含3,5-二氨基-6-(2,3-二氯苯基)-1,2,4-三嗪或r(-)-2,4-二氨基-5-(2,3-二氯苯基)-6-氟甲基嘧啶和nk1的药物组合物
CA2682727C (en)	2007-04-02	2016-03-22	Banyu Pharmaceutical Co., Ltd.	Indoledione derivative
CA2690191C (en)	2007-06-27	2015-07-28	Merck Sharp & Dohme Corp.	4-carboxybenzylamino derivatives as histone deacetylase inhibitors
CN102014631A (zh)	2008-03-03	2011-04-13	泰格尔医药科技公司	酪氨酸激酶抑制剂
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
UA105182C2 (ru)	2008-07-03	2014-04-25	Ньюрексон, Інк.	Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
EP2413932A4 (de)	2009-04-01	2012-09-19	Merck Sharp & Dohme	Hemmer der akt-aktivität
WO2010132437A1 (en)	2009-05-12	2010-11-18	Albany Molecular Research, Inc.	Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
ES2528404T3 (es)	2009-05-12	2015-02-10	Bristol-Myers Squibb Company	Formas cristalinas de (S)-7-([1,2,4]triazol[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y sus usos
CN102595902B (zh)	2009-05-12	2015-04-29	阿尔巴尼分子研究公司	7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉及其用途
NZ599343A (en)	2009-10-14	2014-05-30	Merck Sharp & Dohme	Substituted piperidines that increase p53 activity and the uses thereof
EP2584903B1 (de)	2010-06-24	2018-10-24	Merck Sharp & Dohme Corp.	Neue heterozyklische verbindungen als erk-hemmer
WO2012018754A2 (en)	2010-08-02	2012-02-09	Merck Sharp & Dohme Corp.	RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
EP4079856A1 (de)	2010-08-17	2022-10-26	Sirna Therapeutics, Inc.	Rna-interferenz-vermittelte hemmung der hepatitis b-virus (hbv)-genexpression mittels kurzer interferierender nukleinsäure (sina)
EP2608669B1 (de)	2010-08-23	2016-06-22	Merck Sharp & Dohme Corp.	Neue pyrazolo-[1,5-a-]pyrimidinderivate als mtor-hemmer
EP2613782B1 (de)	2010-09-01	2016-11-02	Merck Sharp & Dohme Corp.	Indazolderivate als erk-hemmer
WO2012036997A1 (en)	2010-09-16	2012-03-22	Schering Corporation	Fused pyrazole derivatives as novel erk inhibitors
ES2663009T3 (es)	2010-10-29	2018-04-10	Sirna Therapeutics, Inc.	Inhibición de la expresión génica mediada por interferencia por ARN utilizando ácidos nucleicos de interferencia cortos (ANic)
EP2654748B1 (de)	2010-12-21	2016-07-27	Merck Sharp & Dohme Corp.	Indazolderivate als erk-hemmer
CA2831730A1 (en)	2011-04-21	2012-10-26	Piramal Enterprises Limited	A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
WO2013004766A1 (en)	2011-07-04	2013-01-10	Ferrari Giulio	Nk-1 receptor antagonists for treating corneal neovascularisation
US9023865B2 (en)	2011-10-27	2015-05-05	Merck Sharp & Dohme Corp.	Compounds that are ERK inhibitors
EP3453762B1 (de)	2012-05-02	2021-04-21	Sirna Therapeutics, Inc.	Sina-zusammensetzungen
US9233979B2 (en)	2012-09-28	2016-01-12	Merck Sharp & Dohme Corp.	Compounds that are ERK inhibitors
WO2014078568A1 (en)	2012-11-14	2014-05-22	The Johns Hopkins University	Methods and compositions for treating schizophrenia
BR112015012295A8 (pt)	2012-11-28	2023-03-14	Merck Sharp & Dohme	Uso de um inibidor de wee1, e, kit para identificar um paciente com câncer
BR112015013611A2 (pt)	2012-12-20	2017-11-14	Merck Sharp & Dohme	composto, e, composição farmacêutica
US9540377B2 (en)	2013-01-30	2017-01-10	Merck Sharp & Dohme Corp.	2,6,7,8 substituted purines as HDM2 inhibitors
US20160194368A1 (en)	2013-09-03	2016-07-07	Moderna Therapeutics, Inc.	Circular polynucleotides
US10975084B2 (en)	2016-10-12	2021-04-13	Merck Sharp & Dohme Corp.	KDM5 inhibitors
IL312486B2 (en)	2017-04-10	2025-05-01	Chase Therapeutics Corp	NK1 antagonist combination and method for treating synucleinopathies
CN106977512B (zh) *	2017-05-04	2019-01-01	海门慧聚药业有限公司	制备马罗匹坦游离碱的方法
KR20250069704A (ko)	2017-06-30	2025-05-19	체이스 테라퓨틱스 코포레이션	우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법
WO2019094311A1 (en)	2017-11-08	2019-05-16	Merck Sharp & Dohme Corp.	Prmt5 inhibitors
EP3706747B1 (de)	2017-11-08	2025-09-03	Merck Sharp & Dohme LLC	Prmt5-inhibitoren
CA3091944A1 (en)	2018-02-26	2019-08-29	Ospedale San Raffaele S.R.L.	Nk-1 antagonists for use in the treatment of ocular pain
KR102102109B1 (ko) *	2018-07-10	2020-04-20	성균관대학교산학협력단	N-벤즈히드릴 퀴뉴클리딘 유도체를 포함하는 나트륨 누출 채널 억제용 조성물
EP3833667B1 (de)	2018-08-07	2024-03-13	Merck Sharp & Dohme LLC	Prmt5-inhibitoren
EP3833668B1 (de)	2018-08-07	2025-03-19	Merck Sharp & Dohme LLC	Prmt5-inhibitoren
AU2019317549A1 (en)	2018-08-07	2021-02-25	Msd International Gmbh	PRMT5 inhibitors
US20230134843A1 (en)	2020-03-11	2023-05-04	Ospedale San Raffaele S.R.L.	Treatment of stem cell deficiency
AT527172A1 (de)	2023-04-25	2024-11-15	Vetviva Richter Gmbh	Maropitantformulierung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX18467A (es) *	1988-11-23	1993-07-01	Pfizer	Agentes terapeuticos de quinuclidinas
AU648317B2 (en) *	1990-06-01	1994-04-21	Pfizer Inc.	3-amino-2-aryl quinuclidines, process for their preparation and pharmaceutical compositions containing them
DE4026743A1 (de) *	1990-08-24	1992-02-27	Teves Gmbh Alfred	Blockiergeschuetzte bremsanlage fuer kraftfahrzeuge
US5716965A (en) *	1991-05-22	1998-02-10	Pfizer Inc.	Substituted 3-aminoquinuclidines
DE122006000066I2 (de) *	1991-05-31	2007-12-06	Pfizer	Chinuclidinderivate
ES2149767T5 (es) *	1991-09-20	2005-06-16	Glaxo Group Limited	Nuevo uso medico para antagonistas de taquiquininas.
GB9218334D0 (en) *	1992-08-28	1992-10-14	Ici Plc	Heterocyclic compounds
US5340826A (en) *	1993-02-04	1994-08-23	Pfizer Inc.	Pharmaceutical agents for treatment of urinary incontinence
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
EP0655246A1 (de) *	1993-11-30	1995-05-31	Pfizer Inc.	Substanz P Antagonisten zur Behandlung von durch Helicobacter Pylori oder andere spirale Urease-positive Gram-negative Bakterien verursachten Krankheiten
US5576317A (en) *	1994-12-09	1996-11-19	Pfizer Inc.	NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
US5990125A (en) *	1996-01-19	1999-11-23	Pfizer Inc.	NK-1 receptor antagonists for the treatment of cancer
EP0785198B1 (de) *	1996-01-19	2000-07-05	Lonza Ag	Verfahren zur Herstellung von optisch aktivem 3-Chinuclidinol

1992
- 1992-04-28 DE DE200612000066 patent/DE122006000066I2/de active Active
- 1992-04-28 CZ CS923906A patent/CZ281403B6/cs not_active IP Right Cessation
- 1992-04-28 RO RO93-01581A patent/RO110499B1/ro unknown
- 1992-04-28 DK DK92912601.9T patent/DK0587723T3/da active
- 1992-04-28 JP JP5500353A patent/JPH0733386B2/ja not_active Expired - Lifetime
- 1992-04-28 WO PCT/US1992/003317 patent/WO1992021677A1/en active IP Right Grant
- 1992-04-28 DE DE69208877T patent/DE69208877T2/de not_active Expired - Lifetime
- 1992-04-28 AU AU19901/92A patent/AU657552B2/en not_active Expired
- 1992-04-28 KR KR1019930703649A patent/KR100214905B1/ko not_active Expired - Lifetime
- 1992-04-28 BR BR9206073A patent/BR9206073A/pt not_active Application Discontinuation
- 1992-04-28 PL PL92301472A patent/PL171379B1/pl unknown
- 1992-04-28 HU HU9303393A patent/HU217548B/hu active Protection Beyond IP Right Term
- 1992-04-28 ES ES92912601T patent/ES2084361T3/es not_active Expired - Lifetime
- 1992-04-28 RU RU93058555A patent/RU2103269C1/ru active Protection Beyond IP Right Term
- 1992-04-28 SK SK3906-92A patent/SK278788B6/sk not_active IP Right Cessation
- 1992-04-28 AT AT92912601T patent/ATE135006T1/de active
- 1992-04-28 US US08/211,120 patent/US5807867A/en not_active Expired - Lifetime
- 1992-04-28 EP EP92912601A patent/EP0587723B1/de not_active Expired - Lifetime
- 1992-04-28 DE DE1992608877 patent/DE122006000066I1/de active Pending
- 1992-04-28 UA UA93004096A patent/UA27776C2/uk unknown
- 1992-04-28 CA CA002102179A patent/CA2102179C/en not_active Expired - Lifetime
- 1992-04-28 DE DE9290063U patent/DE9290063U1/de not_active Expired - Lifetime
- 1992-05-05 TW TW081103509A patent/TW204349B/zh not_active IP Right Cessation
- 1992-05-11 AP APAP/P/1992/000384A patent/AP299A/en active
- 1992-05-26 UY UY23422A patent/UY23422A1/es not_active IP Right Cessation
- 1992-05-26 IL IL10200892A patent/IL102008A/en active Protection Beyond IP Right Term
- 1992-05-29 NZ NZ270673A patent/NZ270673A/en not_active IP Right Cessation
- 1992-05-29 MA MA22826A patent/MA22539A1/fr unknown
- 1992-05-29 MX MX9202554A patent/MX9202554A/es unknown
- 1992-05-29 GT GT199200028A patent/GT199200028A/es unknown
- 1992-05-29 ZA ZA923942A patent/ZA923942B/xx unknown
- 1992-05-29 NZ NZ242956A patent/NZ242956A/en not_active IP Right Cessation
- 1992-05-29 PT PT100546A patent/PT100546B/pt not_active IP Right Cessation
- 1992-05-29 IS IS3871A patent/IS1611B/is unknown
- 1992-05-29 YU YU56492A patent/YU48995B/sh unknown
- 1992-05-30 EG EG28492A patent/EG19944A/xx active
- 1992-05-30 CN CN92104129A patent/CN1048492C/zh not_active Expired - Lifetime
- 1992-07-01 IE IE921729A patent/IE72473B1/en not_active IP Right Cessation
1993
- 1993-11-26 BG BG98248A patent/BG61694B1/bg unknown
- 1993-11-29 NO NO934312A patent/NO302701B1/no not_active IP Right Cessation
- 1993-11-29 FI FI935297A patent/FI114475B/fi not_active IP Right Cessation
- 1993-11-30 OA OA60442A patent/OA09867A/en unknown
1994
- 1994-10-05 JP JP6241456A patent/JP2645225B2/ja not_active Expired - Lifetime
1995
- 1995-01-24 US US08/377,552 patent/US6222038B1/en not_active Expired - Lifetime
1996
- 1996-04-19 GR GR960401066T patent/GR3019687T3/el unknown
1997
- 1997-04-30 US US08/846,909 patent/US5939433A/en not_active Expired - Lifetime
2006
- 2006-12-06 NL NL300250C patent/NL300250I2/nl unknown
- 2006-12-06 LU LU91293C patent/LU91293I2/fr unknown
2007
- 2007-03-09 NO NO2007003C patent/NO2007003I2/no unknown

Also Published As

Publication number	Publication date
CN1048492C (zh)	2000-01-19
PT100546B (pt)	1999-12-31
CA2102179C (en)	1998-10-27
HU217548B (hu)	2000-02-28
DK0587723T3 (da)	1996-04-01
PL171379B1 (en)	1997-04-30
NZ270673A (en)	1997-07-27
NL300250I2 (nl)	2007-03-01
ZA923942B (en)	1993-11-29
SK390692A3 (en)	1998-02-04
PT100546A (pt)	1993-08-31
NZ242956A (en)	1995-06-27
EG19944A (en)	1997-02-27
NO2007003I2 (no)	2011-04-18
DE69208877D1 (de)	1996-04-11
US6222038B1 (en)	2001-04-24
DE122006000066I2 (de)	2007-12-06
TW204349B (de)	1993-04-21
ES2084361T3 (es)	1996-05-01
MA22539A1 (fr)	1992-12-31
HUT70151A (en)	1995-09-28
JP2645225B2 (ja)	1997-08-25
NO2007003I1 (no)	2007-03-26
DE9290063U1 (de)	1994-02-24
CA2102179A1 (en)	1992-12-01
MX9202554A (es)	1992-11-01
FI114475B (fi)	2004-10-29
FI935297L (fi)	1993-11-29
BG61694B1 (bg)	1998-03-31
DE122006000066I1 (de)	2007-03-22
NO302701B1 (no)	1998-04-14
RU2103269C1 (ru)	1998-01-27
NL300250I1 (nl)	2007-02-01
CN1067428A (zh)	1992-12-30
NO934312D0 (no)	1993-11-29
SK278788B6 (sk)	1998-02-04
AU1990192A (en)	1993-01-08
US5939433A (en)	1999-08-17
BR9206073A (pt)	1994-12-06
AP9200384A0 (en)	1992-07-31
GR3019687T3 (en)	1996-07-31
JPH0733386B2 (ja)	1995-04-12
IS3871A (is)	1992-12-02
AP299A (en)	1994-01-14
IL102008A (en)	1995-12-08
WO1992021677A1 (en)	1992-12-10
NO934312L (no)	1993-11-29
KR100214905B1 (ko)	1999-08-02
HU9303393D0 (en)	1994-03-28
EP0587723A1 (de)	1994-03-23
CZ281403B6 (cs)	1996-09-11
JPH06504292A (ja)	1994-05-19
BG98248A (bg)	1994-07-29
AU657552B2 (en)	1995-03-16
LU91293I2 (fr)	2007-02-06
OA09867A (en)	1994-08-15
EP0587723B1 (de)	1996-03-06
JPH07285965A (ja)	1995-10-31
FI935297A0 (fi)	1993-11-29
DE69208877T2 (de)	1996-07-25
YU56492A (sh)	1995-03-27
UA27776C2 (uk)	2000-10-16
RO110499B1 (ro)	1996-01-30
IE921729A1 (en)	1992-12-02
YU48995B (sh)	2003-04-30
UY23422A1 (es)	1992-11-12
IL102008A0 (en)	1992-12-30
CZ390692A3 (en)	1994-02-16
IS1611B (is)	1996-10-18
GT199200028A (es)	1993-11-20
US5807867A (en)	1998-09-15
IE72473B1 (en)	1997-04-23

Publication	Publication Date	Title
DK0587723T3 (da)	1996-04-01	Quinuclidinderivater
FI924160A7 (fi)	1993-03-19	Benzanilidderivat
FI935726A7 (fi)	1993-12-20	Atsanorbornaanijohdannaisia
FI924159L (fi)	1993-03-19	Benzanilidderivat
NO922182L (no)	1992-12-04	Krystallinske oksatiolan-derivater
FI933067A7 (fi)	1993-09-02	Absorptionsprodukt med snabbt fungerande absorberande innedel i flera skikt
FI925422L (fi)	1993-05-30	Indolopyrrolokarbazolderivat
FI921262L (fi)	1992-09-26	4-aryltiazol- eller 4-arylimidazolderivat
NO924890D0 (no)	1992-12-17	Imidazopyridiner
FI925763A0 (fi)	1992-12-18	Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
FI923726L (fi)	1993-02-24	Sulfaterade glykosaminoglykanoidderivat
FI930345L (fi)	1993-01-27	Foerfarande foer framstaellning av renat akrylamidosulfonsyramonomerderivat
FI923342L (fi)	1993-01-25	Pleuromutilinkomplex
FI935243L (fi)	1994-01-11	Pyridonkarboxylsyraderivat
TR26336A (tr)	1995-03-15	SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI
FI925314A7 (fi)	1993-05-27	Cefalosporinderivat
DE69222599D1 (de)	1997-11-13	Cephalosporin-Derivate
FI920394A7 (fi)	1992-08-02	3-kinuklidiinijohdannaiset
DE59207540D1 (de)	1997-01-02	Resolver
MX9206710A (es)	1993-05-01	Derivados de piridinol
FI924145L (fi)	1993-03-18	3-cykloalkylprop-2-enamidderivat
FI921597A7 (fi)	1992-12-04	Maetning av en hisskorgs position med hjaelp av ultraljud
FI942070L (fi)	1994-05-05	Nitroksialkyyliamidijohdannaiset
FI935293A7 (fi)	1993-11-29	Propensyraderivat
FI933346A7 (fi)	1993-07-26	Aminoalkylpyrrolidinyltiokarbapenemderivat